Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel

Colloids and Surfaces B: Biointerfaces

Volumn 117, Issue , 2014, Pages 166-173

  Kulhari, Hitesh ^a   Pooja, Deep ^a   Shrivastava, Shweta ^b   V G M, Naidu ^b   Sistla, Ramakrishna ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Bombesin; Breast cancer; Conjugation; Docetaxel; Nanoparticles; Targeting

Indexed keywords

ATOMIC FORCE MICROSCOPY; BAYESIAN NETWORKS; CELLS; DIFFERENTIAL SCANNING CALORIMETRY; DISEASES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; PEPTIDES; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

BOMBESIN; BREAST CANCER; CONJUGATION; DOCETAXEL; TARGETING;

DRUG PRODUCTS;

BOMBESIN; CHOLIC ACID; DOCETAXEL; GASTRIN RELEASING PEPTIDE RECEPTOR; NANOPARTICLE; POLYGLACTIN; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TAXOID;

ARTICLE; ATOMIC FORCE MICROSCOPY; BREAST CANCER; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY ASSAY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NANOENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE CHARGE; SUSTAINED DRUG RELEASE; THERMOGRAVIMETRY; X RAY DIFFRACTION; ZETA POTENTIAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; TUMOR CELL LINE;

BOMBESIN; CALORIMETRY, DIFFERENTIAL SCANNING; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TAXOIDS; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 84896099133     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.02.026     Document Type: Article

References (34)

1. Byrne J.D., Betancourt T., Brannon-Peppas L. Adv. Drug Deliv. Rev. 2008, 60:1615.
2. Danhier F., Feron O., Préat V. J. Control. Release 2010, 148:135.
3. Oliveira R., Zhao P., Li N., Maria L.C.S., Vergnaud J., Ruiz J., Astruc D., Barratt G. Int. J. Pharm. 2013, 10.1016/j.ijpharm.2013.05.031.
4. Venishetty V.K., Samala R., Komuravelli R., Kuncha M., Sistla R., Diwan P.V. Nanomed. Nanotechnol. Biol. Med. 2013, 9:388.
5. Prakash J., Beljaars L., Harapanahalli A.K., Zeinstra-Smith M., de Jager-Krikken A., Hessing M., Steen H., Poelstra K. Int. J. Cancer 2010, 126:1966.
6. Pimm M., Perkins A., Duncan R., Ulbrich K. J. Drug Target. 1993, 1:125.
7. David A., Kopečková P., Minko T., Rubinstein A., Kopeček J. Eur. J. Cancer 2004, 40:148.
8. Kim J.H., Bae S.M., Na M.H., Shin H., Yang Y.J., Min K.H., Choi K.Y., Kim K., Park R.-W., Kwon I.C. J. Control. Release 2012, 157:493.
9. Mo Y., Lim L.Y. J. Control. Release 2005, 108:244.
10. Yu C., Hu Y., Duan J., Yuan W., Wang C., Xu H., Yang X.D. PLoS ONE 2011, 6:e24077.
11. Manjappa A.S., Chaudhari K.R., Venkataraju M.P., Dantuluri P., Nanda B., Sidda C., Sawant K.K., Murthy R.S.R. J. Control. Release 2011, 150:2.
12. Xu S., Olenyuk B.Z., Okamoto C.T., Hamm-Alvarez S.F. Adv. Drug Deliv. Rev. 2012, 65:121.
13. Reubi J.C. Endocr. Rev. 2003, 24:389.
14. Wang M., Thanou M. Pharmacol. Res. 2010, 62:90.
15. Zhang X.X., Eden H.S., Chen X. J. Control. Release 2012, 159:2.
16. Yu D.H., Lu Q., Xie J., Fang C., Chen H.Z. Biomaterials 2010, 31:2278.
17. Danhier F., Vroman B., Lecouturier N., Crokart N., Pourcelle V., Freichels H., JérÔme C., Marchand-Brynaert J., Feron O., Préat V. J. Control. Release 2009, 140:166.
18. Luo G., Yu X., Jin C., Yang F., Fu D., Long J., Xu J., Zhan C., Lu W. Int. J. Pharm. 2010, 385:150.
19. Anastasi A., Erspamer V., Bucci M. Experientia 1971, 27:166.
20. Sancho V., Di Florio A., Moody T.W., Jensen R.T. Curr. Drug Deliv. 2011, 8:79.
21. Hwang C. Ther. Adv. Med. Oncol. 2012, 4:329.
22. Zhao P., Astruc D. ChemMedChem 2012, 7:952.
23. Xu Z., Chen L., Gu W., Gao Y., Lin L., Zhang Z., Xi Y., Li Y. Biomaterials 2009, 30:226.
24. Musumeci T., Ventura C.A., Giannone I., Ruozi B., Montenegro L., Pignatello R., Puglisi G. Int. J. Pharm. 2006, 325:172.
25. Danhier F., Ansorena E., Silva J.M., Coco R., Le Breton A., Préat V. J. Control. Release 2012, 161:505.
26. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70(1/2):1-20.
27. De Jong W.H., Borm P.J. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3(2):133-149.
28. Kulhari H., Kulhari D.P., Singh M.K., Sistla R. Colloids Surf. A 2014, 443:459-466.
29. Fredenberg S., Wahlgren M., Reslow M., Axelsson A. Int. J. Pharm. 2011, 415:34.
30. Yoo J.Y., Kim J.M., Seo K.S., Jeong Y.K., Lee H.B., Khang G. Biomed. Mater. Eng. 2005, 15:279.
31. Chao C., Ives K., Hellmich H.L., Townsend C.M., Hellmich M.R. J. Surg. Res. 2009, 156:26.
32. Holliday D.L., Speirs V. Breast Cancer Res. 2011, 13(215):1-7.
33. Acharya S., Sahoo S.K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv. Drug Deliv. Rev. 2011, 63:170.
34. Koziara J.M., Whisman T.R., Tseng M.T., Mumper R.J. J. Control. Release 2006, 112:312.